Literature DB >> 17498006

A case report of plasmapheresis and cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis: recovery of renal function after five months on dialysis.

Lily Oliveira1, Donald Wang, Brendan B McCormick.   

Abstract

We describe a patient who presented with nephrotic syndrome and progressive renal failure with biopsy findings of focal segmental glomerulosclerosis (FSGS). He progressed rapidly to end-stage renal disease (ESRD) and remained hemodialysis dependent for five months despite high dose prednisone therapy. Initiation of plasmapheresis and low dose oral cyclophosphamide resulted in the prompt return of urine output and renal recovery. He remains off dialysis with stable renal function (creatinine clearance = 40 mL/min) two years later. This is the first report of late rescue from apparent ESRD due to FSGS with combined plasmapheresis and low dose oral cyclophosphamide.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17498006     DOI: 10.1111/j.1744-9987.2007.00470.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  2 in total

Review 1.  Childhood nephrotic syndrome--current and future therapies.

Authors:  Larry A Greenbaum; Rainer Benndorf; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2012-06-12       Impact factor: 28.314

2.  Treatment with Cyclophosphamide for steroid-resistant nephrotic syndrome in children.

Authors:  Florentina Cucer; Ingrith Miron; Robert Müller; Codruta Iliescu Halitchi; Doina Mihaila
Journal:  Maedica (Buchar)       Date:  2010-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.